Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes

Abstract Following recent advances in post-thrombectomy stroke care, the role of neuroinflammation and neuroprotective strategies in mitigating secondary injury has gained prominence. Yet, while neuroprotection and anti-inflammatory agents have re-emerged in clinical trials, their success has been l...

Full description

Saved in:
Bibliographic Details
Main Authors: Youssef M. Zohdy, Tomas Garzon-Muvdi, Jonathan A. Grossberg, Daniel L. Barrow, Brian M. Howard, Gustavo Pradilla, Firas H. Kobeissy, Stephen Tomlinson, Ali M. Alawieh
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-024-03316-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559189515665408
author Youssef M. Zohdy
Tomas Garzon-Muvdi
Jonathan A. Grossberg
Daniel L. Barrow
Brian M. Howard
Gustavo Pradilla
Firas H. Kobeissy
Stephen Tomlinson
Ali M. Alawieh
author_facet Youssef M. Zohdy
Tomas Garzon-Muvdi
Jonathan A. Grossberg
Daniel L. Barrow
Brian M. Howard
Gustavo Pradilla
Firas H. Kobeissy
Stephen Tomlinson
Ali M. Alawieh
author_sort Youssef M. Zohdy
collection DOAJ
description Abstract Following recent advances in post-thrombectomy stroke care, the role of neuroinflammation and neuroprotective strategies in mitigating secondary injury has gained prominence. Yet, while neuroprotection and anti-inflammatory agents have re-emerged in clinical trials, their success has been limited. The neuroinflammatory response in cerebral ischemia is robust and multifactorial, complicating therapeutic approaches targeting single pathways. In this study, we aimed to characterize early inflammatory gene dysregulation following ischemic stroke using translational in-silico and in-vivo approaches. Using an in vivo ischemic stroke model, transcriptomic analysis revealed significant dysregulation of inflammatory genes. Graph theory analysis then showed a rich-club organization among stroke-related genes, with highly connected core nodes. The expression levels of the core genes identified within this network significantly explained radiological outcomes, including T2-signal hyperintensity (R2 = 0.57, P < 0.001), mean diffusivity (R2 = 0.52, P < 0.001), and mean kurtosis (R2 = 0.65, P < 0.001), correlating more strongly than non-core genes. Similar findings were observed with functional and cognitive outcomes, showing R2 values of 0.58, 0.7, 0.54, and 0.7 for neurological severity scores, corner tasks, passive avoidance, and novel object recognition tasks, respectively (P < 0.001). Using in-silico analysis, we identified a set of upstream regulators directly interacting with core network nodes, leading to simulations that highlighted C3-targeted therapy as a potential treatment. This hypothesis was then confirmed in vivo using a targeted C3 inhibitor (CR2-fH), which reversed gene dysregulation in the neuroinflammatory network and improved radiological and functional outcomes. Our findings underscore the significance of neuroinflammation in stroke pathology, supporting network-based therapeutic targeting and demonstrating the benefits of targeted complement inhibition in enhancing outcomes through modulation of the neuroinflammatory network core. This study’s approach, combining graph theory analysis along with in-silico modeling, offers a promising translational pipeline applicable to stroke and other complex diseases.
format Article
id doaj-art-0c25f4a7c15747e39ee1368e2bc89ab4
institution Kabale University
issn 1742-2094
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj-art-0c25f4a7c15747e39ee1368e2bc89ab42025-01-05T12:41:55ZengBMCJournal of Neuroinflammation1742-20942025-01-0122111610.1186/s12974-024-03316-zComplement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomesYoussef M. Zohdy0Tomas Garzon-Muvdi1Jonathan A. Grossberg2Daniel L. Barrow3Brian M. Howard4Gustavo Pradilla5Firas H. Kobeissy6Stephen Tomlinson7Ali M. Alawieh8Department of Neurosurgery, Emory University School of MedicineDepartment of Neurosurgery, Emory University School of MedicineDepartment of Neurosurgery, Emory University School of MedicineDepartment of Neurosurgery, Emory University School of MedicineDepartment of Neurosurgery, Emory University School of MedicineDepartment of Neurosurgery, Emory University School of MedicineDepartment of Neurobiology, Morehouse School of MedicineDepartment of Microbiology and Immunology, Medical University of South CarolinaDepartment of Neurosurgery, Emory University School of MedicineAbstract Following recent advances in post-thrombectomy stroke care, the role of neuroinflammation and neuroprotective strategies in mitigating secondary injury has gained prominence. Yet, while neuroprotection and anti-inflammatory agents have re-emerged in clinical trials, their success has been limited. The neuroinflammatory response in cerebral ischemia is robust and multifactorial, complicating therapeutic approaches targeting single pathways. In this study, we aimed to characterize early inflammatory gene dysregulation following ischemic stroke using translational in-silico and in-vivo approaches. Using an in vivo ischemic stroke model, transcriptomic analysis revealed significant dysregulation of inflammatory genes. Graph theory analysis then showed a rich-club organization among stroke-related genes, with highly connected core nodes. The expression levels of the core genes identified within this network significantly explained radiological outcomes, including T2-signal hyperintensity (R2 = 0.57, P < 0.001), mean diffusivity (R2 = 0.52, P < 0.001), and mean kurtosis (R2 = 0.65, P < 0.001), correlating more strongly than non-core genes. Similar findings were observed with functional and cognitive outcomes, showing R2 values of 0.58, 0.7, 0.54, and 0.7 for neurological severity scores, corner tasks, passive avoidance, and novel object recognition tasks, respectively (P < 0.001). Using in-silico analysis, we identified a set of upstream regulators directly interacting with core network nodes, leading to simulations that highlighted C3-targeted therapy as a potential treatment. This hypothesis was then confirmed in vivo using a targeted C3 inhibitor (CR2-fH), which reversed gene dysregulation in the neuroinflammatory network and improved radiological and functional outcomes. Our findings underscore the significance of neuroinflammation in stroke pathology, supporting network-based therapeutic targeting and demonstrating the benefits of targeted complement inhibition in enhancing outcomes through modulation of the neuroinflammatory network core. This study’s approach, combining graph theory analysis along with in-silico modeling, offers a promising translational pipeline applicable to stroke and other complex diseases.https://doi.org/10.1186/s12974-024-03316-zStrokeRich-clubNetwork analysisTranscriptomicsComplement inhibition
spellingShingle Youssef M. Zohdy
Tomas Garzon-Muvdi
Jonathan A. Grossberg
Daniel L. Barrow
Brian M. Howard
Gustavo Pradilla
Firas H. Kobeissy
Stephen Tomlinson
Ali M. Alawieh
Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes
Journal of Neuroinflammation
Stroke
Rich-club
Network analysis
Transcriptomics
Complement inhibition
title Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes
title_full Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes
title_fullStr Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes
title_full_unstemmed Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes
title_short Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes
title_sort complement inhibition targets a rich club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes
topic Stroke
Rich-club
Network analysis
Transcriptomics
Complement inhibition
url https://doi.org/10.1186/s12974-024-03316-z
work_keys_str_mv AT youssefmzohdy complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes
AT tomasgarzonmuvdi complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes
AT jonathanagrossberg complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes
AT daniellbarrow complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes
AT brianmhoward complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes
AT gustavopradilla complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes
AT firashkobeissy complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes
AT stephentomlinson complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes
AT alimalawieh complementinhibitiontargetsarichclubwithintheneuroinflammatorynetworkafterstroketoimproveradiographicandfunctionaloutcomes